In a country like India, where we are facing a far heavier burden of genetic disorders, the transformation to data-driven ...

Despite affecting every woman, menopause remains one of the most under-discussed, under-researched, and under-treated phases ...

A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...

Genomic testing demand in India rises rapidly with deeper reach into Tier 2 and 3 cities, driven by affordability, awareness, ...

Manufacturers of the RTS,S shot will begin an immediate phased reduction in cost, with an ultimate aim to reduce the price to ...

Kindly share this postThe manufacturers of the world’s first malaria vaccine are set to slash the price by more than half by ...